Euan Macpherson
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 5
- PARP inhibition in cancer therapy 3
- Cancer Immunotherapy and Biomarkers 2
-
- Lung Cancer Diagnosis and Treatment 2
- Advanced Breast Cancer Therapies 1
- Co-authors
- James Carmichael (3 shared papers)Gordon J.S. Rustin (1 shared paper)Ronnie Shapira‐Frommer (1 shared paper)Ursula A. Matulonis (1 shared paper)Werner Meier (1 shared paper)Jonathan A. Ledermann (1 shared paper)Claire L Watkins (1 shared paper)Clare Scott (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)The Lancet Oncology (1 paper)Annals of Oncology (1 paper)Pharmaceutical Statistics (1 paper)Journal of Chromatography B (1 paper)
- Partner nations
- United KingdomUnited StatesTürkiye
In The Last Decade
Euan Macpherson
8 papers receiving 3k citations
Euan Macpherson's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 1.6k
- Reproductive Medicine 533
- Cancer Research 292
- Genetics 368
- Pulmonary and Respiratory Medicine 262
Countries citing papers authored by Euan Macpherson
This map shows the geographic impact of Euan Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Euan Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Euan Macpherson more than expected).
Fields of papers citing papers by Euan Macpherson
This network shows the impact of papers produced by Euan Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Euan Macpherson. The network helps show where Euan Macpherson may publish in the future.
Co-authors
The 25 scholars most cited alongside Euan Macpherson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer Hit paper breakdown → | 2012 | 1554 |
| 2 | Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study Hit paper breakdown → | 2011 | 966 |
| 3 | 2009 | 252 | |
| 4 | 2008 | 206 | |
| 5 | 2011 | 142 | |
| 6 | 2019 | 11 | |
| 7 | 2015 | 2 | |
| 8 | 5-Year survival data of durvalumab after chemoradiotherapy for unresectable stage III NSCLC - an update from the PACIFIC Study | 2021 | 1 |
About Euan Macpherson
Euan Macpherson is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Statistics and Probability, Molecular Biology and Nuclear Energy and Engineering, having authored 8 papers that have together received 3.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Metabolomics and Mass Spectrometry Studies (1 paper), Advanced Breast Cancer Therapies (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Oncology (1.6k citations), Reproductive Medicine (533 citations), Cancer Research (292 citations), Genetics (368 citations) and Pulmonary and Respiratory Medicine (262 citations). Euan Macpherson has collaborated with scholars based in United Kingdom, United States and Türkiye. Frequent co-authors include James Carmichael, Gordon J.S. Rustin, Ronnie Shapira‐Frommer, Ursula A. Matulonis, Werner Meier, Jonathan A. Ledermann, Claire L Watkins, Clare Scott, Charlie Gourley and Tamar Safra. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, Annals of Oncology, Pharmaceutical Statistics and Journal of Chromatography B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.